This is the authors' abstract. We don't add key points for this paper.
Satisfactory treatment for patients with unresectable advanced lung cancer has not yet been established. We report a case of unresectable advanced lung cancer (stage IIIb: T2aN3M0) treated with a total of 15 doses of dendritic cells pulsed with a Wilms' tumor 1 and mucin 1 vaccine in combination with erlotinib, a small molecule epidermal growth factor receptor tyrosine kinase inhibitor, for more than 699 days without recurrence or metastasis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kosumi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: